NCT03564301 - Metronidazole as an Adjunct of Non- Surgical Treatment of Peri-implantitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 3, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

December 22, 2020

Conditions

Peri-Implantitis

Interventions

DRUG

Placebo oral capsule

Immediately after the end of non surgical treatment of periimplantitis and depending on the result of randomization, the exact number of tablets of the placebo to be taken during the following days will be given to the patient.

DRUG

Metronidazole 250 MG

Immediately after the end of non surgical treatment of periimplantitis and depending on the result of randomization, the exact number of tablets of the antibiotic to be taken during the following days will be given to the patient.

Trial Locations (1)

15782

Department of periodontology, faculty of Odontology, Santiago de Compostela